Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld
AstraZeneca’s Evusheld has been approved for use by the Medicines and Healthcare products Regulatory Agency (MHRA). It is the first antibody preparation approved in the UK to prevent coronavirus infection. The drug is recommended for those who are at risk for COVID-19 due to their underlying disease or other non-vaccination reasons.
Related news
Medicines, yes, but we don’t look for healing on the Internet
In the case of a health complaint they have not…
Read more >
BENU and Foglaljorvost.hu signed a cooperation agreement
Hungary’s best-known pharmacy network and the country’s largest healthcare appointment…
Read more >
More related news >
Related news
NGM: the lives of families are significantly affected by food and health expenses and fuel prices
According to the surveys, the most significant expenses of the…
Read more >
Tesco is making good progress with the sustainability project
Tesco is committed to sustainable operations and has set ambitious…
Read more >
Treasures of Regions – domestic delicacies on the shelves of SPAR
SPAR Hungary helps domestic small producers to enter the market…
Read more >
